After Ch. 11 and Martin Shkreli, Peninsula biotech looks to tackle Covid's 'cytokine storm' with emergency use OK

Investors appeared nonplussed, dropping Humanigen stock Friday by 11%, or $2.51 per share, to $20.23.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news